Exelixis, Inc. (EXEL): Price and Financial Metrics

Exelixis, Inc. (EXEL): $20.91

0.32 (-1.51%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

A

Add EXEL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#7 of 362

in industry

EXEL Price/Volume Stats

Current price $20.91 52-week high $24.34
Prev. close $21.23 52-week low $18.64
Day low $20.76 Volume 1,548,100
Day high $21.21 Avg. volume 2,284,137
50-day MA $22.81 Dividend yield N/A
200-day MA $22.03 Market Cap 6.34B

EXEL Stock Price Chart Interactive Chart >


Exelixis, Inc. (EXEL) Company Bio


Exelixis is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. The company was founded in 1994 and is based in San Francisco, California.


EXEL Latest News Stream


Event/Time News Detail
Loading, please wait...

EXEL Latest Social Stream


Loading social stream, please wait...

View Full EXEL Social Stream

Latest EXEL News From Around the Web

Below are the latest news stories about EXELIXIS INC that investors may wish to consider to help them evaluate EXEL as an investment opportunity.

11 Stocks Insiders and Billionaires Are Crazy About

In this article, we will take a detailed look at the 11 Stocks Insiders and Billionaires Are Crazy About. For a quick overview of such stocks, read our article 5 Stocks Insiders and Billionaires Are Crazy About. In his famous book titled One Up on Wall Street, Peter Lynch talks about how average investors miss out on opportunities by […]

Yahoo | December 19, 2023

Is the Options Market Predicting a Spike in Exelixis (EXEL) Stock?

Investors need to pay close attention to Exelixis (EXEL) stock based on the movements in the options market lately.

Yahoo | December 12, 2023

Why Is Beam Therapeutics Inc. (BEAM) Up 29.5% Since Last Earnings Report?

Beam Therapeutics Inc. (BEAM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 8, 2023

Exelixis 2023 R&D Day: Science & Strategy to be Webcast on December 12, 2023

ALAMEDA, Calif., December 07, 2023--Exelixis, Inc. (Nasdaq: EXEL) today announced that it will webcast the Exelixis 2023 R&D Day: Science & Strategy event taking place on Tuesday, December 12, 2023, from 9:00 a.m. to 12:30 p.m. EST. During the event, featured speakers will review the progress of the company’s growing research and development pipeline, highlight recent clinical updates and elaborate on the company’s continued efforts to serve more patients with cancer and generate sustainable, lo

Yahoo | December 7, 2023

Biotech Stock Roundup: EXEL Partners RCUS for Study, PHVS & EYPT Gain on Study Data

Updates from Exelixis (EXEL) and Pharvaris (PHVS) are in the spotlight this week.

Yahoo | December 7, 2023

Read More 'EXEL' Stories Here

EXEL Price Returns

1-mo -7.03%
3-mo 2.10%
6-mo -0.10%
1-year 5.66%
3-year -11.40%
5-year 6.63%
YTD -12.84%
2023 49.56%
2022 -12.25%
2021 -8.92%
2020 13.90%
2019 -10.42%

Continue Researching EXEL

Here are a few links from around the web to help you further your research on Exelixis Inc's stock as an investment opportunity:

Exelixis Inc (EXEL) Stock Price | Nasdaq
Exelixis Inc (EXEL) Stock Quote, History and News - Yahoo Finance
Exelixis Inc (EXEL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!